SARS-CoV-2 (COVID-19) and the Endocrine System.

Autor:	Lundholm MD; Department of Internal Medicine, Loyola University Medical Center, Maywood, Illinois., Poku C; Department of Medicine, Division of Endocrinology, Loyola University Health Care System, Maywood, Illinois., Emanuele N; Department of Medicine, Division of Endocrinology, Loyola University Health Care System, Maywood, Illinois.; Endocrinology Section, Medical Service, VA Hospital, Hines, Illinois., Emanuele MA; Department of Medicine, Division of Endocrinology, Loyola University Health Care System, Maywood, Illinois., Lopez N; Department of Medicine, Division of Endocrinology, Loyola University Health Care System, Maywood, Illinois.
Jazyk:	angličtina
Zdroj:	Journal of the Endocrine Society [J Endocr Soc] 2020 Oct 01; Vol. 4 (11), pp. bvaa144. Date of Electronic Publication: 2020 Oct 01 (Print Publication: 2020).
DOI:	10.1210/jendso/bvaa144
Abstrakt:	As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system. This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function. Findings in this area are evolving, and long-term effects of infection remain an active area of further research. (© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu